| J1437 | Injection, ferric derisomaltose, 10 mg | 6,200 | $20 | $105.4K |
| J0897 | Injection, denosumab, 1 mg | 4,860 | $20 | $87.5K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 770 | $100 | $76.7K |
| Q5106 | Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | 9,020 | $10 | $54.1K |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | 8,700 | $10 | $52.2K |
| Q5111 | Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg | 430 | $110 | $46.2K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 290 | $120 | $32.9K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 390 | $70 | $27.5K |
| J1442 | Injection, filgrastim (g-csf), excludes biosimilars, 1 microgram | 18,420 | $1 | $18.4K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 130 | $140 | $18K |